Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening

Recruiting now · Not applicable

Conditions studied: Mammographic Breast Density, Mammography

In brief

The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.

Key facts

Study ID

NCT04904757

Run by

University of Virginia

People needed

210

Starts

2019-09-19

Expected to finish

2023-06-01

Last updated by the study team

2022-11-17

Who can join

Age: 40 and older, up to 69. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• • Female
• 40 to 69 years
• Previous normal mammogram (BI-RADS 1 or 2) showing heterogeneous or extremely dense breast tissue within last 24 months
• Scheduled for screening mammogram as part of the patient's clinical care

You may not qualify if…

• • No mammogram within last 24 months
• Fatty or scattered fibroglandular tissue on last mammogram
• History of allergy to iodinated contrast
• History of renal disease or renal function abnormalities
• Pregnant women
• History of diabetes
• History of paraproteinemia syndromes such as multiple myeloma
• History of collagen vascular disease
• History of vascular disease (coronary artery disease, myocardial infarction, carotid disease, peripheral vascular disease, or known visceral artery disease)
• Previously identified as high risk for breast cancer (>20% lifetime risk)
• Asthma
• Sickle Cell Anemia
• Currently on Dialysis

Where it is running

• UVA Breast Care Center — Charlottesville, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.